Thursday, February 03, 2011 2:17:02 PM
Two different products, while both CYRX and Entropy Solutions service the medical industry,
CYRX requires shipments to be made frozen, Entropy, freezing, with alternative ranges offered.
CYRX holding period, 10 days, Entropy, 24 hours up till 4 days.
While there is one company that has a similar product that matches CYRX, they sell there's at a cost of almost 8-10 times compared to renting. Just to try emulate the business model, even if someone attempted it,
would be extremely difficult, but not impossible. At this point in time, No competition exist.
While the container is the core, the added value services are the key.
You can judge for yourself.
http://www.greenboxsystems.com/
http://www.chartbiomed.com/p_vapor_shippers.cfm (similar container)
CYRX requires shipments to be made frozen, Entropy, freezing, with alternative ranges offered.
CYRX holding period, 10 days, Entropy, 24 hours up till 4 days.
While there is one company that has a similar product that matches CYRX, they sell there's at a cost of almost 8-10 times compared to renting. Just to try emulate the business model, even if someone attempted it,
would be extremely difficult, but not impossible. At this point in time, No competition exist.
While the container is the core, the added value services are the key.
You can judge for yourself.
http://www.greenboxsystems.com/
http://www.chartbiomed.com/p_vapor_shippers.cfm (similar container)
Recent CYRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 10:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:30:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/10/2025 09:10:52 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2025 07:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 07:33:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 10:18:14 PM
- Cryoport Reports Third Quarter 2025 Financial Results • PR Newswire (US) • 11/04/2025 09:05:00 PM
- Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain • PR Newswire (US) • 10/30/2025 12:30:00 PM
